The Methylation Cycle and Homocysteine
Every second, your cells hand around millions of tiny methyl groups (—CH3) — the chemical tags that switch genes on and off, build myelin and creatine, and dispose of used-up neurotransmitters. Watch the gold CH3 tokens travel from folate through the MTHFR enzyme, get handed to homocysteine by vitamin B12, and be delivered by SAMe — then knock out a cofactor and watch the traffic jam: homocysteine piles up in the tank and the numbers turn red.
Try this: press B12 deficiency and watch the folate trap — 5-MTHF fills to the brim but cannot let go of its methyl group. Then press 5-MTHF + B2 and notice it does not fix a B12 problem. Press Methionine load in B6 deficiency to see the escape route fail.
Live methylation readout
What's happening
The Science in Plain Language
Methylation: your body's CH₃ economy
A methyl group is chemistry's smallest useful tag — one carbon and three hydrogens (—CH3). Your cells attach and remove these tags billions of times a second, and the list of jobs that depend on them is startling: switching genes on and off (DNA methylation), building the myelin and cell membranes that insulate nerves (via phosphatidylcholine), manufacturing creatine for muscle and brain energy, turning serotonin into melatonin, and clearing spent neurotransmitters and oestrogen (the COMT enzyme). Creatine synthesis and phosphatidylcholine synthesis together consume the largest share of all the methyl groups you use.
Almost every one of those transfers is done by a single molecule: SAMe (S-adenosylmethionine), the universal methyl donor. Each time SAMe hands over its methyl group it becomes SAH (S-adenosylhomocysteine), and SAH is then split into homocysteine and adenosine. That is the crucial insight this animation is built around: homocysteine is not a poison your body sets out to make. It is the ash left behind every time you methylate something. A healthy cell disposes of it as fast as it appears — a high blood level usually means the disposal machinery has run out of vitamins.
The folate cycle: where methyl groups are made
Methyl groups have to come from somewhere, and the main factory is the folate cycle (left of the diagram). Synthetic folic acid — from supplements and fortified flour — enters as an inactive form and must be reduced by the enzyme DHFR to DHF and then THF (tetrahydrofolate). Natural food folate from leafy greens, legumes and liver largely arrives already partway through the cycle.
THF then collects a spare carbon from the amino acid serine (a step that itself needs vitamin B6) to become 5,10-methylene-THF. Finally the enzyme MTHFR — which uses riboflavin (vitamin B2) as its cofactor — reduces that to 5-MTHF, the finished, methyl-loaded, active folate. Two features of this step matter enormously:
- The MTHFR reaction is essentially one-way. Once folate has become 5-MTHF it cannot go back.
- Methionine synthase is the only exit. 5-MTHF has exactly one customer, and if that customer isn't working, the folate is stuck.
The methionine cycle, and why homocysteine exists at all
Dietary protein supplies methionine. Combined with ATP (the MAT enzyme), methionine becomes SAMe; SAMe donates its methyl and becomes SAH; SAH is hydrolysed to homocysteine. Because you keep eating protein, this production line keeps running — which is precisely why homocysteine builds up when its exits are blocked. Homocysteine has only three ways out, and the animation shows all three:
- Methionine synthase — takes the methyl from 5-MTHF; needs vitamin B12.
- BHMT — takes a methyl from betaine; needs no folate and no B12.
- Transsulfuration — the CBS enzyme sends it out of the cycle for good; needs vitamin B6.
Typical fasting total plasma homocysteine is about 5–15 µmol/L. Most laboratories flag anything above ~15 µmol/L as elevated, and many clinicians aim for under 10. In the rare inherited disease homocystinuria it can exceed 100 µmol/L.
Vitamin B12 and the folate trap
This is the single most important idea on the page. Methionine synthase does not move the methyl group directly from folate to homocysteine — it parks it on a B12 atom first, then passes it on. Take B12 away and the enzyme stalls with its hands full.
Now follow the consequences in the animation. Folate keeps arriving and MTHFR keeps converting it to 5-MTHF — but 5-MTHF cannot go backwards and has nowhere else to go. The tank fills to the brim: this is the “methyl-folate trap”. Inside the cell you now have a functional folate deficiency even though a blood folate test may look perfectly normal or even high. Meanwhile homocysteine keeps being produced from dietary methionine, cannot be remethylated, and rises.
Two clinical points follow directly, and they are not trivia:
- Folate does not rescue a B12 deficiency. Press “+ 5-MTHF & B2” while B12 deficiency is on: the tank simply fills further and homocysteine barely moves. In real patients, giving folic acid can partially correct the anaemia of B12 deficiency while the neurological damage keeps advancing — numbness, unsteady gait, memory change. Always establish B12 status first.
- MMA tells the two apart. B12 has a second job (as adenosylcobalamin) in the enzyme that clears methylmalonyl-CoA. So B12 deficiency raises both homocysteine and methylmalonic acid (MMA), while folate deficiency raises homocysteine only. That is exactly how the laboratory distinguishes them — watch the MMA line in the readout.
The betaine / choline shortcut (BHMT)
Your liver and kidneys keep a second, entirely independent way home. The enzyme BHMT takes a methyl group from betaine (trimethylglycine) and hands it straight to homocysteine — no folate, no B12, no MTHFR involved. Betaine comes from your diet (beets, spinach, wheat bran, quinoa) and from the oxidation of choline, which is richest in egg yolks and liver. In the liver, this shortcut can carry a large share of total remethylation.
Turn on “+ Betaine / choline” in any scenario and watch homocysteine come down. Betaine (typically around 6 g/day in trials) reliably lowers fasting homocysteine, and pharmaceutical betaine anhydrous is an established treatment for homocystinuria. It is a genuine bypass — but note that it recycles homocysteine back into methionine rather than removing it from the body.
Transsulfuration: the B6 escape route to glutathione
Only one pathway permanently removes homocysteine, and it turns the waste into something precious. The enzyme CBS (cystathionine β-synthase), which needs vitamin B6 in its active form, joins homocysteine to serine to make cystathionine. A second B6-dependent enzyme splits that into cysteine — and cysteine is the rate-limiting ingredient for glutathione, your cells' master antioxidant. Your body literally builds its main antioxidant defence out of its methylation waste.
Switch on B6 deficiency: the escape hatch closes, the glutathione meter falls, and homocysteine backs up. But here the honest detail matters — in B6 deficiency, fasting homocysteine often rises only modestly. The transsulfuration route mostly handles surges, so the deficit shows up dramatically after a protein/methionine load. That is why the classic methionine-loading test exists. Press “Methionine load” with B6 deficiency on and watch the spike climb far higher and clear far more slowly than it does in the normal scenario.
One more piece of elegant, slightly cruel design: SAMe switches CBS on and MTHFR off. When SAMe is plentiful, homocysteine is pushed down the transsulfuration route. When SAMe is low — exactly what happens in B12 or folate deficiency — CBS is turned down and homocysteine is steered toward remethylation, the very route that is blocked. That is part of why deficiency states raise homocysteine so sharply.
MTHFR C677T — what the evidence actually says
C677T is a common, ordinary variant in the MTHFR gene, not a disease. People with two copies (TT) make a heat-sensitive enzyme with roughly 30% of normal activity in the test tube. It is genuinely common — around 10% of people in many European and North American populations are TT, with much higher and much lower rates elsewhere.
And yet the real-world effect is modest, which the internet rarely admits:
- TT typically raises fasting homocysteine by only a few µmol/L compared with the common CC genotype — and that difference is largely confined to people whose folate intake is low. With good folate status, the gap between TT and CC narrows substantially. Nutrition matters more than the genotype.
- Riboflavin (B2) is MTHFR's own cofactor and stabilises the variant enzyme; riboflavin supplementation lowers homocysteine specifically in TT individuals.
- 5-MTHF (methylfolate) supplements skip the MTHFR step entirely, which is why they are marketed so hard to this group. They work — but so, for most people, does ordinary folate or folic acid, because MTHFR at 30% activity is still working.
- The American College of Medical Genetics and Genomics recommends against routine MTHFR genotype testing (including in workups for clotting or recurrent pregnancy loss). If your homocysteine is high, the useful question is almost always “what is my B12, folate and B6 status?”, not “what is my genotype?”
Finally, does lowering homocysteine cure anything? B vitamins lower it dependably — folic acid alone by roughly a quarter, with a further small drop when B12 is added. But the large randomised trials of B-vitamin supplements (NORVIT, HOPE-2, SEARCH) did not reduce heart attacks, although meta-analyses suggest a modest reduction in stroke. Trials in older adults with mild cognitive impairment and raised homocysteine (VITACOG) found B vitamins slowed the rate of brain shrinkage. The fair summary: a high homocysteine is a real and useful signal — usually of a correctable B12, folate or B6 problem — but it is a smoke alarm, not the fire. Correct the deficiency because the deficiency itself matters.